• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Luitpold Pharms’ Generic Epinephrine Receives Tentative Approval in the US

    FDA

    Luitpold Pharms Generic Hydroxyprogesterone Caproate Receives Approval In US

    FDA

    Daiichi Sankyo US subsidiary, Luitpold Pharma to merge with its own subsidiaries

    PHARMABIZ

    Luitpold Pharms Generic Neostigmine Methylsulfate Receives Approval In US

    FDA

    Luitpold Pharm’s Generic Calcium Chloride Receives Approval In US

    FDA

    Luitpold Pharm’s Generic Testosterone Cypionate Receives Approval In US

    FDA

    Luitpold Pharms Oxaliplatin Receives Approval In Us

    Par Pharmaceutical, Inc. v. Luitpold Pharmaceuticals, Inc.

    PRESS RELEASE

    Amring Pharmaceuticals Acquired Six ANDAs

    PR NEWSWIRE

    Luitpold Pharms Inc`s Generic Dicyclomine Hydrochloride Receives Approval In US

    FDA

    Broken Market for Old Drugs Means Price Spikes Are Here to Stay

    BLOOMBERG

    Egalet To Hire Up To 60 Sales Reps For Launch Of Two Pain Medicines

    PHILADELPHIA BUSINESS JOURNAL

    Luitpold`s Generic Esmolol Hydrochloride (Esmolol Hydrochloride 10Mg/mL) Approved in USA for Supraventricular Tachyarrhythmias And Noncompensatory Sinus Tachycardia.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.